[Effect of a revascularization procedure on functioning of the hibernating myocardium]
Related Experiment Video
Updated: Oct 24, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
M Aschermann1, I Vanĕk, V Vondrácek
1II. interní klinika 1. lékarské fakulty Univerzity Karlovy, Praha.
Insights
Low-dose dobutamine echocardiography accurately identifies hibernating myocardium in coronary artery disease patients, predicting wall motion improvement after revascularization.
Area of Science:
- Cardiology
- Medical Imaging
- Cardiac Physiology
Background:
- Chronic coronary artery disease often leads to persistent left ventricular dysfunction.
- Hibernating myocardium, a state of impaired contractility due to reduced blood flow, has significant prognostic implications.
- Identifying viable myocardium is crucial for guiding therapeutic decisions in patients with left ventricular dysfunction.
Purpose of the Study:
- To evaluate the efficacy of low-dose dobutamine echocardiography in detecting hibernating myocardium.
- To assess the predictive value of dobutamine echocardiography for wall motion recovery after coronary revascularization.
- To compare the diagnostic accuracy of dobutamine echocardiography before and after revascularization procedures.
Main Methods:
- Studied 32 patients with confirmed coronary artery disease and left ventricular dysfunction.
- Utilized low-dose dobutamine infusion (5 and 10 micrograms/kg/min) during echocardiography.
- Assessed left ventricular function and wall motion before and at two time points after revascularization (percutaneous coronary angioplasty or coronary artery bypass grafting).
Main Results:
- Dobutamine echocardiography identified 122 out of 226 dysfunctional myocardial segments as viable.
- Significant improvement in segment score index was observed after dobutamine infusion and post-revascularization.
- The method demonstrated high sensitivity (84-85%) and specificity (85-90%) in predicting early and late functional recovery.
Conclusions:
- Low-dose dobutamine echocardiography is a safe and accurate tool for identifying hibernating myocardium.
- This technique effectively predicts the reversibility of left ventricular wall motion abnormalities post-revascularization.
- Dobutamine stress echocardiography aids in patient selection for revascularization, optimizing therapeutic outcomes.
Abstract:
Persistent abnormalities of left ventricular wall motion in patients with chronic coronary artery disease can be reversed by successful coronary artery bypass surgery or coronary angioplasty. The identification of hibernating myocardium has therefore important therapeutic and prognostic implications. Echocardiography with low dose dobutamine infusion can detect viable myocardium in patients with chronic left ventricular dysfunction. We have studied 32 patients with angiographically confirmed coronary artery disease and left ventricular dysfunction. The effect of dobutamine infusion (5 micrograms/kg/min. followed by 10 micrograms/kg/min) on left ventricular function was evaluated before coronary revascularization (PTCA, n = 20); CABGm b = 12) and compared with early period after revascularization (1-7 days) and 6-7 months later. Before revascularization 226 segments were hypokinetic, akinetic or dyskinetic, improvement was observed in 122 segments during dobutamine echocardiography. Mean (+/- SD) segment score indexes were 2.50 +/- 0.17 at baseline, 2.04 +/- 0.19 (p < 0.001) after dobutamine infusion, 2.24 +/- 0.25 (p < 0.001) early after and 1.87 +/- 0.25 (p < 0.001) late after revascularization. Sensitivity of dobutamine infusion to predict improvement early and late after revascularization was 84% and 85% respectively, specificity was 85% and 90% respectively. Echocardiography during low dose dobutamine infusion is save and accurate method for identifying of hibernating myocardium and predicts early and late reversibility of wall motion in selected patients with coronary artery disease and chronic left ventricular dysfunction.
More Related Videos
07:50Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023